Table 2 Interviews with investigators
From: Triangulating perspectives on functional neuroimaging for disorders of mental health
Coded themes/Subthemes | Number of interviews in |  Coded themes/Subthemes | Number of interviews in |
|---|---|---|---|
| Â | which coded themes and | Â | which coded themes and |
| Â | subthemes occur/total N | Â | subthemes occur/total N |
| Â | (N = 28) | Â | (N = 28) |
Goals of research | Â | Risks to participants | Â |
  Treatment choice | 9 |   Noise, claustrophobia | 11 |
  Prediction | 7 |   Incidental findings | 9 |
  Monitoring | 5 |   False hope for treatment | 8 |
  Treatment | 4 |   Distrust of science or medicine | 3 |
  Diagnosis | 3 |   Inaccurate diagnosis | 6 |
  Pre-surgical planning | 3 |   Increased stigma | 5 |
  Defining populations | 1 |   Negative self-understanding | 4 |
Challenges |  |   Distrust of science or medicine | 3 |
  Scientific challenges | 12 |   Breach of confidentiality | 2 |
  Funding challenges | 8 |   Discrimination (e.g., insurance) | 2 |
  Technical limitations | 5 |   None (explicitly) | 3 |
  Heterogeneous protocols | 1 | Future of neuroimaging |  |
  Participant recruitment | 4 |   Clinical trials needed | 16 |
  Ethics review itself | 2 |   Clinical trials not needed | 1 |
  Balancing research with care | 2 |   Larger samples | 13 |
  Obtaining informed consent | 1 |   Multi site trials | 12 |
  Lack of creativity in the field | 2 |   Controlled studies | 7 |
Potential benefits |  |   Blinded trials | 5 |
  Improved care | 9 |   Randomized trials | 5 |
  Better understanding illness | 6 |   Longitudinal studies | 2 |
  Reduced stigma | 5 |   Add-on studies | 2 |
  Improved self-attitude | 1 |   Standardized imaging protocols | 6 |
  New knowledge | 2 |   Different models of disease | 2 |
  None (explicitly) | 2 |   Drug trials | 2 |
| Â | Â | Clinical Uptake | Â |
|  |  |   Demand from clinicians | 1 |
|  |  |   Science not ready | 11 |